Why the study?
What is the prevalence and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease?
What is the prevalence and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease?
Masked and white-coat hypertension are relatively common in patients with chronic kidney disease and are associated with target organ damage.
Prevalence of WCHT and MHT was 10.21% and 16.11%, respectively. WCHT and MHT show a close relationship with TOD in CKD patients.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: